Trial reportScientific reports2026
The role of temporomandibular joint mobilization in the management of benign paroxysmal positional vertigo: randomized controlled trial.
Trial report in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05944159 (Is the Temporamandibular Joint and Soft Tissue Mobilization Technique Effective in Individuals Diagnosed With Bening Paroxysmal Positional Vertigo?), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Is the Temporamandibular Joint and Soft Tissue Mobilization Technique Effective in Individuals Diagnosed With Bening Paroxysmal Positional Vertigo?
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Benign paroxysmal positional vertigo (BPPV) is the most common peripheral vestibular disorder and is characterized by brief episodes of vertigo triggered by changes in head position. Although canalith repositioning maneuvers effectively treat the underlying mechanical pathology, cranio-cervical musculoskeletal factors may influence dizziness perception and postural control. Temporomandibular joint (TMJ) dysfunction has been associated with vestibular symptoms, including dizziness, imbalance, and tinnit us. This study evaluated the effectiveness of TMJ and soft tissue mobilization as an adjunct to standard treatment in individuals with BPPV. In this parallel-group randomized controlled trial, 42 adults diagnosed with BPPV were randomly allocated using simple randomization to an intervention group or a control group. One participant was excluded due to non-adherence, and 41 participants completed the study (intervention n = 20; control n = 21; mean age 53.9 ± 9.8 years). The intervention group received TMJ and soft tissue mobilization once weekly for four weeks in addition to canalith repositioning maneuvers, while the control group received standard treatment alone. The primary outcome was dizziness-related disability assessed using the Dizziness Disability Inventory. Additional outcomes included assessments of temporomandibular function and postural balance. Independent t-tests, Mann-Whitney U tests, paired t-tests, and Wilcoxon tests were applied. Both groups demonstrated significant improvements in dizziness-related outcomes (p < 0.001). However, no significant between-group differences were observed for dizziness measures. The intervention group showed significantly greater improvement in temporomandibular function (p < 0.001). In addition, balance performance during tandem stance with eyes open improved significantly more in the intervention group compared with the control group (mean difference 3.90 s; 95% CI 1.70-6.10; p = 0.001). Adding temporomandibular joint and soft tissue mobilization to conventional treatment may improve balance performance and temporomandibular function in individuals with benign paroxysmal positional vertigo.Clinical trial registration number: ClinicalTrials.gov (NCT05944159; 24 July 2023).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.